Gain More Insights. Make Better Decisions.
Transforming Biologics Discovery through Innovation
The promise of biotherapeutics
Biologic drugs have transformed modern medicine and their continued evolution gives greater promise for many patients with serious or untreatable conditions, most notably cancer.
Meeting the challenges of biologics development
Attrition rates of the drug discovery process are still very high. To accelerate research and increase the chances of success with drug development programs, you need translational data and insights that expedite decision-making and help you make better predictions regarding the safety and efficacy of your drug candidates.
Translational Insights. Streamlined workflows. Reduced development costs.
Sartorius provides scientists with innovative, groundbreaking solutions and technologies to enable translational insights and streamlined workflows that accelerate and improve the outcomes of preclinical trials, helping to enhance your productivity and reduce the time and cost of drug development.
Monoclonal Antibody Discovery and Development for Oncology Research
Information-rich solutions for development of antibody therapeutics and antibody-drug conjugates that enable tracking of complex biological processes at unprecedented speed, depth, and scale.
Viral Vaccines & Vectors
Recombinant viral vaccines bring new perspective in the prevention of infectious diseases. Viral vectors are also widely used for gene therapy and oncolytic applications. Speed up the development of new vaccine candidates for fighting diseases.
Biosimilar Development
At the heart of all biosimilar development is a comprehensive comparability study.
See how can we support your robust analytical data package.